52% of all brain tumors and has a very poor prognosis

Glioblastoma Multiforme accounts for 52% of all brain tumors and has a very poor prognosis. „The current standard of care (SOC) of GBM involves surgery followed by adjuvant fractionated radiotherapy and chemotherapy. However, little progress has been made in extending overall survival, progression-free survival, and quality of life.“ Read here about the combination of radiotherapy and immunotherapy in the treatment of GBM and the „exciting potential for harnessing the immune modulatory effects or radiation through combinatorial strategies designed to enhance clinical outcome.“

 

https://www.ncbi.nlm.nih.gov/m/pubmed/28567588/